Across TCGA pan-cancer cohorts, EPPIN-WFDC6 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated EPPIN-WFDC6 data layer compared with 1 for mutation status.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher EPPIN-WFDC6 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated EPPIN-WFDC6 expression acts as an unfavorable survival marker, although some lineages such as LUAD and SKCM show a favorable association.
KIRC, LUAD, and STAD are the cancer types where EPPIN-WFDC6 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.